Therapy-related leukemia. A panmyelosis
- 1. Univ. of Minnesota, Minneapolis
Description
Fifteen patients developed acute nonlymphocytic leukemia (ANLL) 31 to 182 months following chemotherapy and/or radiotherapy for various malignancies and one non-neoplastic disorder. The ANLL was commonly heralded by a brief preleukemic phase consisting of cytopenias and a variety of morphologic abnormalities. At diagnosis of ANLL, all of the patients had a panmyelosis with variation in the predominant abnormal cell line. Neutrophilic and erythroid abnormalities were most striking in 12 of the patients, megakaryocytic abnormalities predominated in 2, and monocytic abnormalities in 1. Pancytopenia, marked anisopoikilocytosis, normoblastemia, large hypogranular platelets, hypogranular neutrophils, pseudo-Pelger--Huet nuclei, low myeloblast counts, and basophilia were the most common abnormalities in the blood. Bone marrows were hypercellular with increased myeloblasts and basophils, abnormal neutrophil precursors, occasional monocytoid blasts, dyserythropoiesis with PAS positive erythroblasts, ring sideroblasts, and micromegakaryocytes. All of the 7 patients who had bone marrow chromosome studies exhibited major chromosomal abnormalities. Response to anti-leukemic therapy was poor. The morphologic and clinical findings of these 15 patients appear to define a clinical-pathologic entity
Additional details
Publishing Information
- Journal Title
- Cancer
- Journal Volume
- 43
- Journal Issue
- 4
- Series
- Cancer.
- Journal Page Range
- 1285-1296
- ISSN
- 0008-543X
INIS
- Country of Publication
- United States
- Country of Input or Organization
- United States
- INIS RN
- 10487249
- Subject category
- S63: RADIATION, THERMAL, AND OTHER ENVIRONMENTAL POLLUTANT EFFECTS ON LIVING ORGANISMS AND BIOLOGICAL MATERIALS; S62: RADIOLOGY AND NUCLEAR MEDICINE; S62: RADIOLOGY AND NUCLEAR MEDICINE;
- Descriptors DEI
- ALKYLATING AGENTS; BIOLOGICAL EFFECTS; BLOOD CELLS; BONE MARROW; CHEMOTHERAPY; CHROMOSOMAL ABERRATIONS; CHROMOSOMES; DELAYED RADIATION EFFECTS; IONIZING RADIATIONS; IRRADIATION; LEUKEMIA; PATIENTS; RADIATION EFFECTS; RADIOSENSITIVITY; RADIOTHERAPY; SIDE EFFECTS
- Descriptors DEC
- ANTIMITOTIC DRUGS; BIOLOGICAL MATERIALS; BIOLOGICAL RADIATION EFFECTS; BLOOD; BODY; BODY FLUIDS; DISEASES; DRUGS; HEMATOPOIETIC SYSTEM; HEMIC DISEASES; MEDICINE; MUTATIONS; NEOPLASMS; ORGANS; RADIATIONS; THERAPY; TISSUES